Masimo Corp Files Definitive Additional Proxy Materials

TL;DR

Masimo filed more proxy docs, shareholder vote incoming.

AI Summary

Masimo Corporation filed definitive additional materials on June 17, 2024, related to its proxy statement. The filing concerns the company's Schedule 14A information, which is used for soliciting shareholder votes. No fee was required for this filing.

Why It Matters

This filing provides shareholders with important supplemental information regarding Masimo Corporation's proxy statement, which is crucial for upcoming shareholder decisions and voting.

Risk Assessment

Risk Level: low — This filing is routine administrative material for a proxy statement and does not contain new financial or strategic information that would inherently increase risk.

Key Players & Entities

• MASIMO CORPORATION (company) — Registrant
• 0001213900-24-053129.txt (document) — Filing identifier
• 20240617 (date) — Filing date

FAQ

Key Financial Figures

• $1 b — nctions, damages and payments exceeding $1 billion, and related business agreements

Filing Documents

• ea0207975-defa14a_masimo.htm (DEFA14A) — 77KB
• image_001.jpg (GRAPHIC) — 3KB
• image_002.jpg (GRAPHIC) — 608KB
• image_003.jpg (GRAPHIC) — 302KB
• image_004.jpg (GRAPHIC) — 406KB
• image_005.jpg (GRAPHIC) — 677KB
• 0001213900-24-053129.txt ( ) — 2827KB

From the Filing

ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 MASIMO CORPORATION (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. On June 17, 2024, Masimo Corporation (“Masimo” or the “Company”) issued a press release announcing that it has filed its definitive proxy statement and sent a letter to its stockholders regarding Masimo’s 2024 annual meeting of stockholders. A copy of the press release and the letter are set forth below. Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders Strongly Encourages Stockholders to Vote FOR Joe Kiani and Christopher Chavez on the GOLD Proxy Card Warns Stockholders of Politan’s Value-Destructive Agenda Should It Gain Control Highlights Masimo’s Track Record of Innovation, Longstanding Premium Valuation, Strong Long-Term Plan and Superior Director Nominees Visit ProtectMasimosFuture.com for More Information IRVINE, Calif. – June 17, 2024 – Members of the Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) Board of Directors today issued a letter to stockholders in connection with its definitive proxy materials filed on June 17, 2024, and the Company’s Annual Meeting of Stockholders to be held on July 25, 2024. The letter highlights what in our view are the significant risks to the value of Masimo if control of the Board is ceded to Politan Capital Management (“Politan”), which we believe wants to eliminate some of the key people and practices that have fueled Masimo’s long-term innovation and growth and supported its premium valuation multiple. The letter also details the Company’s excellent positioning to continue to drive above-market organic growth and meaningful margin expansion, while highlighting the expertise and experience of Masimo’s highly qualified director nominees. To protect stockholders’ investment and the Company’s future, the Board strongly encourages stockholders to vote FOR Masimo’s exceptional director nominees, Joe Kiani and Christopher Chavez. Find our definitive proxy materials and more information on why your vote is critical to the future of Masimo at www.ProtectMasimosFuture.com. The full text of the Board’s letter to our stockholders can be found here: Dear Fellow Masimo Stockholders: At the upcoming Annual Meeting of Stockholders, you face a choice: electing your Board’s nominees – Joe Kiani, the founder, Chairman and CEO of Masimo, and Christopher Chavez, a highly experienced and independent former CEO and director of public medical device companies – or adding two more nominees hand-picked and paid by Politan, thereby ceding control of Masimo to Politan. This election is critical to the future of Masimo and the value of your investment in our stock. As independent directors who have served on Masimo’s Board alongside Politan directors Quentin Koffey and Michelle Brennan, it’s clear to us that they have no understanding of Masimo’s business. Innovation and revenue growth have supported Masimo’s longstanding valuation premium to medical technology peers, but we believe Politan wants to eliminate some of the key people and practices that drive Masimo’s innovation and growth. The risk of their agenda is immense. Masimo has earned its valuation through innovation that has driven consistent organic growth, consistently taking share in existing markets with clinically superior products and creating new markets with new technologies and applications. Mr. Kiani leads this process with a team that drives and is driven by him. We are concerned that replacing this approach and team with Politan’s inexperience and what we believe is a misguided agenda will destroy Masimo’s innovation engine, slow organic growth, and dramatically depress Masimo’s valuation multiple. 1 A year ago, Politan rebuffed Masimo’s assertion that Politan was seek

View Full Filing

View this DEFA14A filing on SEC EDGAR